ClinicalTrials.Veeva

Menu

Reporting of Adverse Events in Patients Treated With New Oral Anticoagulants

H

Hvidovre University Hospital

Status

Completed

Conditions

Bleeding as Complication to Anticoagulation Therapy

Study type

Observational

Funder types

Other

Identifiers

NCT02107651
01675-HVH-2012-010-999

Details and patient eligibility

About

Serious adverse events in patients treated with new oral anticoagulants are underreported.

Full description

The study investigates if serious adverse events in patients treated with NOAC are reported to the Health and Medicines Authority.

Enrollment

20 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients admitted for GI bleeding while in treatment with NOAC

Exclusion criteria

  • none

Trial design

20 participants in 1 patient group

NOAC
Description:
Patients admitted for GI bleeding while in treatment with NOAC

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems